KRISHNA PHARMA LTD

Company Registration Number:
07187143 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2024

Period of accounts

Start date: 01 April 2023

End date: 31 March 2024

KRISHNA PHARMA LTD

Contents of the Financial Statements

for the Period Ended 31 March 2024

Balance sheet
Notes

KRISHNA PHARMA LTD

Balance sheet

As at 31 March 2024


Notes

2024

2023


£

£
Fixed assets
Intangible assets: 3 2,995,316 2,995,316
Tangible assets: 4 53,686 56,066
Investments: 5 6,178 6,178
Total fixed assets: 3,055,180 3,057,560
Current assets
Stocks: 100,681 148,169
Debtors: 6 181,750 259,338
Cash at bank and in hand: 94,191 200,044
Total current assets: 376,622 607,551
Creditors: amounts falling due within one year: 7 (857,411) (757,311)
Net current assets (liabilities): (480,789) (149,760)
Total assets less current liabilities: 2,574,391 2,907,800
Creditors: amounts falling due after more than one year: 8 (2,130,400) (2,536,200)
Total net assets (liabilities): 443,991 371,600
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 443,891 371,500
Shareholders funds: 443,991 371,600

The notes form part of these financial statements

KRISHNA PHARMA LTD

Balance sheet statements

For the year ending 31 March 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 06 September 2024
and signed on behalf of the board by:

Name: R Patel
Status: Director

The notes form part of these financial statements

KRISHNA PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

KRISHNA PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

2. Employees

2024 2023
Average number of employees during the period 16 17

KRISHNA PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

3. Intangible Assets

Total
Cost £
At 01 April 2023 2,995,316
At 31 March 2024 2,995,316
Net book value
At 31 March 2024 2,995,316
At 31 March 2023 2,995,316

KRISHNA PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

4. Tangible Assets

Total
Cost £
At 01 April 2023 153,515
Additions 8,833
At 31 March 2024 162,348
Depreciation
At 01 April 2023 97,449
Charge for year 11,213
At 31 March 2024 108,662
Net book value
At 31 March 2024 53,686
At 31 March 2023 56,066

KRISHNA PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

5. Fixed investments

OTHER INVESTMENT 10 YEARS AGO

KRISHNA PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

6. Debtors

2024 2023
££
Debtors due after more than one year: 0 0

KRISHNA PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

7. Creditors: amounts falling due within one year note

Bank loan 9798 Trade creditors 769088 Taxation 19074 Other creditors 59451

KRISHNA PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

8. Creditors: amounts falling due after more than one year note

LOANS